title: Treatment with a proton pump inhibitor improves glycaemic control in type 2 diabetic patients - a retrospective analysis.
abstract: We retrospectively studied whether treatment with esomeprazole improved HbA₁(c) levels in type 2 diabetic patients. We selected 21 patients who had been treated with esomeprazole for 11 ± 3 months and 21 controls. HbA₁(c) levels decreased in the esomeprazole-treated group. Our data indicate that proton pump inhibitors may improve glycaemic control in type 2 diabetic patients.
authors.affiliation: Steno Diabetes Center, Niels Steensens Vej 2, DK-2820 Gentofte, Denmark.
authors.forename: Karin D
authors.initials: KD
authors.lastname: Hove
authors.forename: Kristine
authors.initials: K
authors.lastname: Færch
authors.forename: Thóra B
authors.initials: TB
authors.lastname: Bödvarsdóttir
authors.forename: Allan E
authors.initials: AE
authors.lastname: Karlsen
authors.forename: Jacob S
authors.initials: JS
authors.lastname: Petersen
authors.forename: Allan
authors.initials: A
authors.lastname: Vaag
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001786:Blood Glucose; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D064098:Esomeprazole / Q000627:therapeutic use*; D005260:Female; D006442:Glycated Hemoglobin / Q000378:metabolism; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D054328:Proton Pump Inhibitors / Q000627:therapeutic use*; D012189:Retrospective Studies
chemical_list: D001786:Blood Glucose; D064098:Esomeprazole; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D054328:Proton Pump Inhibitors